Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Search

Reset Filter
You have a filtered search result

16 search results for ‘*’


Outside the Lab Public health

Patients, Be Not Afraid

| Ben Beckley | 2 min read

How we can begin overcoming patients’ fears and misconceptions of cell and gene therapy


Tools & Techniques Diagnostics & prognostics

Taking the Long View: Strategies for SARS-CoV-2 Surveillance

| Angelica Olcott, Vanitha Margan | 8 min read

Diagnosis and tracking of SARS-CoV-2 and its variants require different platforms and technologies, intelligently combined

Tools & Techniques Diagnostics & prognostics

Embracing Tissue Models

| Hannah C. Lamont

Disease research should embrace the biotechnology available to increase drug development success

Research Field Drug discovery

The Final Frontier for Regenerative Medicine

| Stephanie Sutton

What will drug development look like aboard a new commercial space station?

Tools & Techniques Analytical science

Cell Therapy’s Live Analytical Challenges

| Dalip Sethi

Analytical science can take cell therapy manufacturing to the next level: in-line measurement of critical quality attributes

Tools & Techniques Diagnostics & prognostics

A (Consistently) Bright Future

| Matt Sergent

Technologies such as automation can help bring laboratory cytogenetics techniques into the future

Outside the Lab Professional development

Opening the Door for All

| Adil Menon

When participating in or supporting patient-physician conversations, pathologists must work to alleviate racial and ethnic disparities

Research Field Neuroscience

We Need to Talk About Clinical Representation

Alzheimer’s research should benefit all, regardless of ethnicity or race

Tools & Techniques Clinical trials

The SCOPE of Things to Come

| Paulo Eduardo Stanga

It is your responsibility to encourage patients to join the SCOPE study

Disease Area Neurological

Getting on Target for Alzheimer’s

| Neil Cashman, James Kupiec

"Biogen revitalizes hope for Alzheimer’s therapy, but their work highlights why we still need greater selectivity."

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register